There are currently no generic Humulin 70/30 products available. Like all insulins, Humulin 70/30 is considered to be a "biologic" medication, and generic biologics are not allowed to be manufactured in the United States. It is impossible to predict at this time when (or even if) any generic versions of this drug will become available.
Is a Generic Version of Humulin 70/30 Available?
Humulin® 70/30 (NPH insulin/regular insulin) is a non-prescription diabetes medication. It contains a combination of 30 percent regular insulin (a short-acting insulin) and 70 percent NPH insulin (an intermediate-acting insulin). It is typically taken twice a day before meals.
Humulin 70/30 is made by Eli Lilly and Company. At this time, there are no generic versions of Humulin 70/30 (or any other insulin medications) available. There are other insulin mixtures available, but none of them are equivalent to Humulin 70/30 (and probably more importantly, none of them are generic medications).
Obstacles to Generic Insulin
Like all insulins, Humulin 70/30 is considered to be a "biologic" medication. As a result, it is regulated by different rules and laws than most other medications. At this point, generic biologics (including generic Humulin 70/30) are not allowed to be manufactured in the United States. Currently, legislation is underway that may change the laws concerning generic biologics, but it is not clear when (or even if) this may happen.
At this point, it is impossible to predict when (or even if) a generic version of Humulin 70/30 may become available.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Humulin 70/30 [package insert]. Indianapolis, IN: Lily USA, LLC;2013 March.
Humulin 70/30 Vial [patient package insert]. Indianapolis, IN: Eli Lilly and Company;2007 August.
Humulin 70/30 Pen [patient package insert]. Indianapolis, IN: Eli Lilly and Company;2007 August.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed October 27, 2008.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click